Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Leukemia × eryaspase × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Neoplasms 1 Leukemia, Myeloid, Acute 1 Leukemia 1

Interventions

Cyclophosphamide 206 Cytarabine 175 fludarabine phosphate 119 Methotrexate 113 Filgrastim 112 Etoposide 92 Busulfan 87 Rituximab 76 Peripheral Blood Stem Cell Transplantation 71 fludarabine 68 Vincristine 67 Radiotherapy 67 Daunorubicin 60 Dexamethasone 55 Antilymphocyte Serum 54 Cyclosporine 53 Melphalan 49 Tacrolimus 46 Imatinib Mesylate 45 Mycophenolic Acid 43 Whole-Body Irradiation 41 Granulocyte Colony-Stimulating Factor 41 Mercaptopurine 40 Idarubicin 40 Methylprednisolone 37 Flow Cytometry 37 Doxorubicin 37 Clofarabine 36 Prednisone 34 Asparaginase 34

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01810705 2022-02-21

ENFORCE

ERYtech Pharma

Phase 2 Completed

123 enrolled 8 charts

Other hematologic neoplasm

Leukemia, Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon ⚡